Brenntag, the global market leader in chemical distribution, is entering the micronization and fine milling segment in Germany and Europe. To this end, the company this week acquired ACU PHARMA und CHEMIE group (ACU), Germany.
According to Karsten Beckmann, Member of the Board of Management of Brenntag Group and CEO Brenntag Europe, Middle East and Africa, “The core competence of ACU in the area of ultra-fine milling of solids allows us to continue expanding our portfolio of value-added services, particularly for customers in the Life Science segment. The acquisition brings us powerful expertise as well as plant technology for a variety of services. We can now offer our customers an additional advantage by positioning Brenntag as a reliable, efficient partner in this part of the supply chain as well.”
ACU specializes in the milling and micronization of products and compound mixtures. In its modern facility, the company produces high quality powders for customers in many different industries. Besides this custom-made contract manufacturing, ACU sells its own micronized products, especially lithium carbonate.
“This acquisition is attractive for several reasons. Brenntag can profit from the outsourcing trend among chemical producers in areas such as micronization which are not core business activities. In addition, we are breaking into the attractive lithium-carbonate distribution business in Germany, Austria and Switzerland,” says Anthony Gerace, Managing Director Mergers & Acquisitions at Brenntag Group.
The acquired business generated sales of approximately 4.5 million EUR in the financial year 2015. Gross profit 2015 amounted to approximately 3.1 million EUR with a normalized EBITDA of about 1.8 million EUR. The investment totals 10.5 million EUR.